Cepham Milk Specialities
No trades in 1Y
Key Insights
Strengths
2- Company has a good return on equity (ROE) track record: 3 Years ROE 32.3%
- Debtor days have improved from 98.4 to 68.9 days.
Weaknesses
2- Company has low interest coverage ratio.
- Company might be capitalizing the interest cost
Growth Rate
Annual windows: The latest annual results are more than two years old, so no annual growth is shown.
Trailing twelve months: No quarterly results are reported.
Not shown: Quarterly Results. Not this company's figures: left behind by an earlier update and not confirmed by the latest one.
Profit & Loss
₹ Cr| Particulars | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 40.37 | 38.64 | 51.96 | 521 | 247 | 11.3 | 13.04 | 14.45 | 25.3 | 28.17 | 22.04 | 16.58 |
| Expenses | 42.64 | 36.37 | 54.44 | 501 | 240 | 8.19 | 12.16 | 14.39 | 25.47 | 26.38 | 22.45 | 16.68 |
| Operating Profit | −2.27 | 2.27 | −2.48 | 19.87 | 6.67 | 3.11 | 0.88 | 0.06 | −0.17 | 1.79 | −0.41 | −0.1 |
| OPM % | −5.62% | 5.87% | −4.77% | 3.81% | 2.7% | 27.52% | 6.75% | 0.42% | −0.67% | 6.35% | −1.86% | −0.6% |
| Other Income | 2.09 | −1.63 | 0.58 | 0.9 | 5.05 | 12.37 | 1.94 | 0.09 | 0.19 | 0.07 | 0.53 | 0.15 |
| Interest | 0.62 | 0.08 | 0.34 | 12.62 | 11.69 | 0.29 | 0.24 | 0.02 | 0.03 | 0.15 | 0.01 | 0.01 |
| Depreciation | 2.39 | 2.4 | 2.39 | 2.36 | 0.18 | 0.2 | 0.15 | 0 | 0 | 0.02 | 0.05 | 0.04 |
| PBT | −3.19 | −1.84 | −4.63 | 5.79 | −0.15 | 14.99 | 2.43 | 0.13 | −0.01 | 1.69 | 0.06 | 0 |
| Tax % | 3.13% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 2.96% | 500% | — |
| Net Profit | −3.28 | −1.84 | −4.63 | 5.79 | −0.15 | 14.99 | 2.44 | 0.12 | −0.01 | 1.65 | −0.24 | 0 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12.5 | 12.5 | 12.5 | 12.5 | 12.5 | 12.5 | 12.5 | 12.5 | 12.5 | 12.5 | 12.5 | 12.5 |
| Reserves | −119 | −106 | −110 | −104 | −105 | −89.62 | −92.92 | −12.34 | −12.35 | −10.7 | −10.94 | −10.94 |
| Borrowings | 131 | 113 | 110 | 297 | 95.7 | 95.73 | 99.47 | 10.96 | 10.47 | 10.61 | 10.55 | 10.55 |
| Other Liabilities | 14.6 | 13.39 | 58.22 | 34.47 | 19.82 | 15.61 | 14.22 | 20.13 | 20.31 | 23.32 | 26.27 | 18.84 |
| Total Liabilities | 39.11 | 33.33 | 70.77 | 240 | 23.41 | 34.22 | 33.27 | 31.25 | 30.93 | 35.73 | 38.38 | 30.95 |
| Fixed Assets | 18.84 | 16.5 | 14.13 | 1.58 | 1.61 | 1.36 | 1.64 | 0 | 0 | 0.13 | 0.14 | 0.11 |
| CWIP | 0 | 0 | 0 | 0.12 | 0.24 | 0.24 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 20.27 | 16.83 | 56.64 | 238 | 21.56 | 32.62 | 31.63 | 31.25 | 30.93 | 35.6 | 38.24 | 30.84 |
| Total Assets | 39.11 | 33.33 | 70.77 | 240 | 23.41 | 34.22 | 33.27 | 31.25 | 30.93 | 35.73 | 38.38 | 30.95 |
Cash Flow
₹ Cr| Particulars | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | — | 2.14 | 3.33 | −154 | 218 | −13.15 | 3.94 | −0.18 | 0.84 | −0.22 | −0.09 | −0.08 |
| Investing | — | −0.06 | −0.02 | 10.24 | −0.17 | 12.3 | −0.17 | 0.04 | 0.04 | −0.11 | −0.02 | 0.03 |
| Financing | — | −2.24 | −2.76 | 146 | 219 | −0.29 | −2.9 | 0.15 | −0.52 | 0.1 | −0.07 | 0 |
| Net Cash Flow | — | −0.16 | 0.55 | 1.47 | 437 | −1.15 | 0.86 | 0.01 | 0.36 | −0.23 | −0.18 | −0.05 |
| Free Cash Flow | — | 2.08 | 3.31 | −144 | 218 | −0.89 | 3.48 | −0.18 | 0.84 | −0.37 | −0.15 | −0.08 |
| CFO/EBITDA | — | 94 | −134 | −778 | 3,273 | −424 | 481 | −283 | −494 | 3 | −132 | 80 |
Ratios
| Particulars | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 77.85 | 75.29 | 332 | 152 | 8.78 | 588 | 442 | 170 | 61.31 | 88.37 | 138 | 68.91 |
| Inventory Days | 65.71 | 52.1 | 20.03 | 4.24 | 3.11 | 162 | 49.57 | 34.24 | 30.02 | 46.45 | 71.98 | 3.41 |
| Days Payable | 130 | 120 | 68.13 | 15.08 | 5.46 | 458 | 193 | 320 | 172 | 374 | 565 | 283 |
| Cash Conversion Cycle | 13.53 | 7.31 | 284 | 142 | 6.43 | 291 | 299 | −115 | −80.27 | −239 | −355 | −210 |
| Working Capital Days | 43.49 | 25.88 | −19.88 | 142 | 5.57 | 624 | 425 | −15.41 | −11.97 | 12.05 | 14.24 | 25.32 |
| ROCE % | −9.76% | −7.92% | −26.41% | 16.91% | 11.05% | 137.12% | 16.94% | — | 0.37% | 15.89% | 0.65% | 0.08% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Cepham Milk Specialities insights
29 extracted metrics across FY09–FY26.
Frequently Asked Questions about Cepham Milk Specialities
Where is Cepham Milk Specialities Ltd (CEPHAMILK) listed?
Company Information
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CEPHAMILK.md for Cepham Milk Specialities Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.